3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
12
Unknown
6
Terminated
4
Recruiting
3
Active not recruiting
2
Not yet recruiting
1
Enrolling by invitation
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
8
Other solid neoplasm
8
Head & Neck
2
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
542
Triple Negative Breast Neoplasms
86
Neoplasms
18
Colorectal Neoplasms
18
Lung Neoplasms
16
Neoplasm Metastasis
15
Advanced Breast Cancer
15
Prostatic Neoplasms
14
Carcinoma, Non-Small-Cell Lung
14
Motor Activity
12
Breast Cancer Lymphedema
12
HER2-positive Breast Cancer
11
Uterine Cervical Neoplasms
10
Stomach Neoplasms
10
Ovarian Neoplasms
10
Endometrial Neoplasms
10
Carcinoma, Intraductal, Noninfiltrating
10
Anxiety Disorders
10
Depression
8
Brain Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
6
Pain, Postoperative
6
Pain
6
Melanoma
6
Lymphedema
6
Head and Neck Neoplasms
6
Colonic Neoplasms
6
Cardiotoxicity
6
Pancreatic Neoplasms
5
Liver Neoplasms
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Mesothelioma, Malignant
×
Breast
×
Clear all
NCT05698238
2023-03-15
CAMP1
Mabpro, a.s.
Phase 1
Not yet recruiting
50 enrolled